HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fucosyltransferase and alpha-L-fucosidase activities and fucose levels in normal and malignant endometrial tissue.

Abstract
Previous immuno- and lectin-histochemical studies using mAbs and Ulex europaeus lectin I, which recognize various fucose-containing blood group antigens, have shown an increased expression of Lewis and H blood group antigens in endometrial carcinoma. We investigated the biochemical basis of aberrant fucose-containing antigen expression by comparing the activity of fucosyltransferases (FTase) and alpha-L-fucosidase in tissue biopsies from normal (n = 18) and malignant (n = 20) endometrium. Alteration of FTase activity in tumor tissue homogenates was evaluated by using a panel of FTase substrates including N-acetyllactosamine (type 2), lacto-N-biose I (type 1), and phenyl-beta-D-galactoside. Based on histological subtyping, the endometrioid group (n = 14) showed a significant (P < 0.05) increase in tumor FTase activity with all three substrates, while no significant increase was detected for the papillary serous group (n = 4). Matched pair analysis of normal and tumor tissue from a subgroup (n = 5) of the patients with increased tumor enzyme activity also showed higher FTase activity (P < 0.05) in the tumor tissue when the type 1 substrate was used. Regression analysis showed a correlation between the FTase activities acting on type 2 or type 1 substrates (r = 0.821 and r = 0.722, respectively) and the endogenous fucose levels in tumor homogenates. Spectrophotometric analysis of alpha-L-fucosidase activity using p-nitrophenyl-alpha-L-fucoside revealed a higher activity in tumor homogenates than in normal homogenates (P < 0.05) and, therefore, could not account for the enhanced expression of fucose-containing antigens. The current study suggests that aberrant expression of fucose-containing antigens, such as the H and the Lewis blood-group antigens, in endometrial carcinoma is consequential to the change in FTase rather than in alpha-L-fucosidase activity. In addition, the investigation suggests that different glycosylation mechanisms are operative in different subtypes of endometrial cancer.
AuthorsJ W Wang, R A Ambros, P B Weber, T G Rosano
JournalCancer research (Cancer Res) Vol. 55 Issue 16 Pg. 3654-8 (Aug 15 1995) ISSN: 0008-5472 [Print] United States
PMID7627975 (Publication Type: Journal Article)
Chemical References
  • ABO Blood-Group System
  • Lewis Blood Group Antigens
  • Fucose
  • Fucosyltransferases
  • alpha-L-Fucosidase
Topics
  • ABO Blood-Group System (metabolism)
  • Adult
  • Aged
  • Carcinoma (embryology)
  • Endometrial Neoplasms (metabolism)
  • Endometrium (metabolism)
  • Female
  • Fucose (metabolism)
  • Fucosyltransferases (metabolism)
  • Humans
  • Lewis Blood Group Antigens (metabolism)
  • Middle Aged
  • alpha-L-Fucosidase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: